Effect of intravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 3080-3089

  Kiagiadaki, Foteini ^a   Thermos, Kyriaki ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANGIOPEPTIN; CHOLINE ACETYLTRANSFERASE; NITRIC OXIDE SYNTHASE; SOMATOSTATIN; AMIDE; DRUG DERIVATIVE; INDOLE DERIVATIVE; L 779976; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; NEUROTOXIN; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; EXCITOTOXICITY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RETINA; RETINA AMACRINE CELL; RETINA CELL; RETINA ISCHEMIA; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYMOLOGY; ISCHEMIA; RETINA BLOOD VESSEL; TIME; VITREOUS BODY;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; AMACRINE CELLS; AMIDES; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOHISTOCHEMISTRY; INDOLES; ISCHEMIA; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; RETINA; RETINAL VESSELS; SOMATOSTATIN; TIME FACTORS; VITREOUS BODY;

EID: 48249119520     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1644     Document Type: Article

References (73)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res. 2004;23:91-147. (Pubitemid 38180539)
2. Brandstätter JH, Koulen P, Wässle H. Diversity of glutamate receptors in the mammalian retina. Vis Res. 1998;38:1385-1397. (Pubitemid 28239261)
3. Liu SJ, Zukin RS. Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci. 2007;30:126-134. (Pubitemid 46283597)
4. Zeevalk GD, Nicklas WJ. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J Pharmacol Exp Ther. 1990;253:1285-1292. (Pubitemid 20209395)
5. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res. 1997;37:3483-3493. (Pubitemid 27491629)
6. Olney J, Price M, Salles KS, Labruyere J, Frierdich G. MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Eur J Pharmacol. 1987;141:357-361. (Pubitemid 17150129)
7. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate- induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992;8:567-573.
8. Huang JC, Salt TE, Voaden MJ, Marshall J. Non-competitive NMDA-receptor antagonists and anoxic degeneration of the ERG B-wave in vitro. Eye. 1991;5:476-580.
9. Cui Q, Harvey AR. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J Neurosci. 1995;15:8143-8155. (Pubitemid 26006918)
10. Osborne NN, Larsen AK. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure: effect of glutamate antagonists. Neurochem Int. 1996;29:263-270. (Pubitemid 26270756)
11. Ferreira IL, Duarte CB, Carvalho AP. Kainate-induced retina amacrine- like cell damage is mediated by AMPA receptors. Neuroreport. 1998;26:3471-3475. (Pubitemid 28566132)
12. Osborne NN, McCord RJ, Wood JPM. The effect of kainate on protein kinase C, GABA, and the uptake of serotonin in the rabbit retina in vivo. Neurochemistry. 1995;20:635-641.
13. Osborne NN, Larsen A, Barnett NL. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells. Invest Ophthalmol Vis Sci. 1995;36:1692-1700.
14. Osborne NN, Herrera AJ. The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina. Neuroscience. 1994;59:1071-1081. (Pubitemid 24149112)
15. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973;179:77-79.
16. Shapiro B, Kronheim S, Pimstone B. The presence of immunoreactive somatostatin in rat retina. Horm Metab Res. 1979;11:79-80. (Pubitemid 9127728)
17. Hoyer D, Bell GI, Berelowitz M, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995;16:86-88.
18. Thermos K. Functional mapping of somatostatin receptors in the retina: a review. Vision Res. 2003;43:1805-1815. (Pubitemid 36773815)
19. Helboe L, Moller M. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophthalmol Vis Sci. 1999;40:2376-2382. (Pubitemid 29418394)
20. Johnson J, Wong H, Walsh JH, Brecha NC. Expression of the somatostatin subtype 2A receptor in the rabbit retina. J Comp Neurol. 1998;393:93-101. (Pubitemid 28120069)
21. Johnson J, Wu V, Wong H, Walsh JH, Brecha NC. Somatostatin receptor subtype 2A expression in the rat retina. Neuroscience. 1999;94:675-683. (Pubitemid 29474956)
22. Vasilaki A, Gardette R, Epelbaum J, Thermos K. NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Invest Ophthalmol Vis Sci. 2001;42:1600-1609. (Pubitemid 32520754)
23. Petrucci C, Resta V, Fieni F, Bigiani A, Bagnoli P. Modulation of potassium current and calcium influx by somatostatin in rod bipolar cells isolated from the rabbit retina via sst2 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2001;363:680-694. (Pubitemid 32477276)
24. Vasilaki A, Papadaki T, Notas G, et al. Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures. Invest Ophthalmol Vis Sci. 2004;45:1499-1506. (Pubitemid 38859331)
25. Cristiani R, Fontanesi G, Casini G, Petrucci C, Viollet C, Bagnoli P. Expression of somatostatin subtype 1 receptor in the rabbit retina. Invest Ophthalmol Vis Sci. 2000;41:3191-3199. (Pubitemid 30691965)
26. Vasilaki A, Mouratidou M, Schulz S, Thermos K. Somatostatin mediates nitric oxide production by activating sst(2) receptors in the rat retina. Neuropharmacology. 2002;43:899-909. (Pubitemid 35217728)
27. Cristiani R, Petrucci C, Dal Monte M, Bagnoli P. Somatostatin (SRIF) and SRIF receptors in the mouse retina. Brain Res. 2002;936:1-14. (Pubitemid 34461928)
28. Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science. 1997;276:1706-1709. (Pubitemid 27421979)
29. Higgins RD, Yan Y, Schrier BK. Somatostatin analogs inhibit neonatal retinal neovascularisation. Exp Eye Res. 2002;74:553-559. (Pubitemid 34757010)
30. Forloni G, Lucca E, Angeretti N, Chiessa R, Vezzani A. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J Neurochem. 1997;68:319-327. (Pubitemid 26427323)
31. Braun H, Schulz S, Becher A, Schroder H, Hollt V. Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain. Brain Res. 1998;803:54-60. (Pubitemid 28392129)
32. Rauca C, Schafer K, Hollt V. Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1999;360:633-638. (Pubitemid 30012462)
33. Reiner PB, Laycock AG, Doll CJ. A pharmacological model of ischemia in the hippocampal slice. Neurosci Lett. 1990;119:175-178. (Pubitemid 20379250)
34. Mastrodimou N, Lambrou GN, Thermos K. Effect of somatostatin analogues on chemically induced ischaemia in the rat retina. Naunyn Schmiederbergs Arch Pharmacol. 2005;371:44-53. (Pubitemid 40379387)
35. Catalani E, Cervia D, Martini D, et al. Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression. Eur J Neurosci. 2007;25:1447-1459. (Pubitemid 46568781)
36. Mastrodimou N, Thermos K. The somatostatin receptor (sst1) modulates the release of somatostatin in rat retina. Neurosci Lett. 2004;356:13-16. (Pubitemid 38121495)
37. Sperk, S, Widmann, R. Somatostatin precursor in the rat striatum: changes after local injection of kainic acid. J Neurochem. 1985;45:1441-1447. (Pubitemid 16252582)
38. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
39. Massey SC, Miller RF. Glutamate receptors of ganglion cells in the rabbit retina: evidence for glutamate as a bipolar cell transmitter. J Physiol. 1988;405:635-655. (Pubitemid 18250358)
40. Yang XL. Characterization of receptors for glutamate and GABA in retinal neurons. Prog Neurobiol. 2004;73:127-150. (Pubitemid 38759893)
41. Hughes TE, Hermans-Borgmeyer I, Heinemann S. Differential expression of glutamate receptor genes (GluR1-5) in the rat retina. Vis Neurosci. 1992;8:49-55.
42. Peng YW, Blackstone CD, Huganir RL, Yau KW. Distribution of glutamate receptor subtypes in the vertebrate retina. Neuroscience. 1995;66:483-497.
43. Lu YM, Yin HZ, Chiang J, Weiss JH. Ca(2+)-permeable AMPA/ kainate and NMDA channels: high rate of Ca2+ influx underlies potent induction of injury. J Neurosci. 1996;16: 5457-5465. (Pubitemid 26277874)
44. Geiger JR, Melcher T, Koh DS, et al. Relative abundance of subunits mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. 1995;15:193-204.
45. Jakobs TC, Ben Y, Masland RH. Expression of mRNA for glutamate receptor subunits distinguishes the major classes of retinal neurons, but is less specific for individual cell types. Mol Vis. 2007;13:933-948. (Pubitemid 46957325)
46. Fischer AJ, Seltner RL, Poon J, Stell WK. Immunocytochemical characterization of quisqualic acid- and N-methyl-D-aspartate-induced excitotoxicity in the retina of chicks. J Comp Neurol. 1998;393:1-15. (Pubitemid 28120061)
47. Firth SI, Li W, Massey SC, Marshak DW. AMPA receptors mediate acetylcholine release from starburst amacrine cells in the rabbit retina. J Comp Neurol. 2003;466:80-90. (Pubitemid 37193687)
48. Sagar SM. NADPH-diaphorase reactive neurons of the rabbit retina: differential sensitivity to excitotoxins and unusual morphologic features. J Comp Neurol. 1990;300:309-319. (Pubitemid 20357790)
49. Blute TA, Velasco P, Eldred WD. Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors. Vis Neurosci. 1998;15:485-498. (Pubitemid 28235804)
50. Dijk F, Kamphuis W. An immunocytochemical study on specific amacrine cell subpopulations in the rat retina after ischemia. Brain Res. 2004;1026:205-217. (Pubitemid 39361549)
51. Singh M, Savitz SI, Hoque R, et al. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J Neurochem. 2001;466-475. (Pubitemid 32298741)
52. de la Villa P, Kurahashi T, Kaneko A. L-glutamate-induced responses and cGMP-activated channels in three subtypes of retinal bipolar cells dissociated from the cat. J Neurosci. 1995;15:3571-3582.
53. Shiells RA, Falk G. The glutamate-receptor linked cGMP cascade of retinal on-bipolar cells is pertussis and cholera toxin-sensitive. Proc Biol Sci. 1992;247:17-20.
54. Kamphuis W, Klooster J, Dijk F. Expression of AMPA-type glutamate receptor subunit (GluR2) in ON-bipolar neurons in the rat retina. J Comp Neurol. 2003;455:172-186. (Pubitemid 35424255)
55. Lin B, Martin PR, Grunert U. Expression and distribution of ionotropic glutamate receptor subunits on parasol ganglion cells in the primate retina. Vis Neurosci. 2002;19:453-465. (Pubitemid 36019867)
56. Brandstätter JH, Hartveit E, Sassoe-Pognetto M, Wässle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci. 1994;6:1100-1112. (Pubitemid 24218385)
57. Tezel G, Wax MB. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci. 1999;40:2660-2667. (Pubitemid 29455497)
58. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci. 1999;40:2697-2705. (Pubitemid 29455502)
59. Dijk F, Van Leeuwen S, Kamphuis W. Differential effects of ischemia- reperfusion on amacrine-cell subtype specific transcript levels in rat retina. Brain Res. 2004;1026:194-204. (Pubitemid 39361548)
60. Celiker U, Ilhan N. Nitric oxide and octreotide in retinal ischemia-reperfusion injury. Doc Ophthalmol. 2002;105:327-338. (Pubitemid 36018753)
61. 2+ current in the pituitary cell line AtT-20. Neuroscience. 1996;71:1073-1081.
62. 2+ current modulated by cGMP-dependent protein kinase. Nature. 1994;369:336-339.
63. Mastrodimou N, Kiagiadaki F, Thermos K. The role of nitric oxide and cGMP in somatostatin's protection against retinal ischemia. Invest Ophthalmol Vis Sci. 2008;49:342-349.
64. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem. 2004;89:1057-1091. (Pubitemid 38720193)
65. Ke JB, Zhong YM. Expression of somatostatin receptor subtype 5 in rat retinal amacrine cells. Neuroscience. 2007;144:1025-1032. (Pubitemid 46014002)
66. Rohrer SP, Birzin ET, Mosley RT, et al. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science. 1998;282:737-740. (Pubitemid 28489384)
67. Bezerra Y, Fuselier JA, Peyman GA, Oner H, Drouant G, Coy DH. Study of inhibitory effects of an antioangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats. Retina. 2005;25:345-354. (Pubitemid 40517365)
68. Hernandez C, Carrasco E, Casamitjana R, Deulofeu R, García- Arumí J, Simó R. Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects. Diabetes Care. 2005;28:1941-1947. (Pubitemid 41060967)
69. Simo R, Carrasco E, Fonollosa A, García-Arumí J, Casamitjana R, Hernández C. Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema. Diabetes Care. 2007;30:725-727. (Pubitemid 46354362)
70. Papadaki T, Zacharopoulos I, Iaccheri B, Fiore T, Foster CS. Somatostatin for uveitic cystoid macular edema (CME). Ocul Immunol Inflamm. 2005;13:469-470. (Pubitemid 41769987)
71. Papadaki T, Tsilimbaris M, Thermos K, et al. The role of lanreotide in the treatment of choroidal neovascularization secondary to age-related macular degeneration: a pilot clinical trial. Retina. 2003;23:800-807. (Pubitemid 38040581)
72. Robertson JE, Westra I, Woltering EA, et al. Intravitreal injection of octreotide acetate. J Ocul Pharmacol Ther. 1997;13:171-177. (Pubitemid 27144344)
73. Liang C, Peyman GA, Conway MD, Woltering EA. Retinal toxicity of intravitreous octreotide in the rabbit. Can J Ophthalmol. 1997;32:229-232. (Pubitemid 27305298)